0.00Open0.05Pre Close0 Volume13 Open Interest7.00Strike Price0.00Turnover534.40%IV396.48%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1092Delta0.1399Gamma28.40Leverage Ratio-0.0108Theta0.0000Rho3.10Eff Leverage0.0005Vega
Outset Medical Stock Discussion
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Monday, 6th January at 8:30 am
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt
Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million
SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ: OM) ("Outset"), a medical technology co...
📊⚡️📊
Larger Image: tradingview.com...
$Outset Medical (OM.US)$
Outset Medical (OM) said Monday that the US Food and Drug Administration has granted 510(k) clearance for TabloCart with prefiltration, an optional accessory to its Tablo Hemodialysis System dialysis machine.
The medical technology company said it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the US.
No comment yet